首页RCEL • NASDAQ
add
AVITA Medical Inc
昨日收盘价
$8.94
当日价格范围
$8.87 - $9.50
年度波幅
$7.51 - $18.93
市值
2.40亿 USD
平均交易量
15.85万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 1954.60万 | 43.25% |
经营支出 | 3016.20万 | 44.75% |
净收入 | -1620.50万 | -86.01% |
净利润率 | -82.91 | -29.85% |
每股收益 | -0.93 | -75.60% |
息税折旧摊销前利润 | -1349.60万 | -47.63% |
有效税率 | 0.17% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 4440.50万 | -26.14% |
总资产 | 8105.10万 | 0.05% |
负债总额 | 6882.40万 | 281.59% |
权益总额 | 1222.70万 | — |
发行在外的股份 | 2621.76万 | — |
市净率 | 19.02 | — |
资产回报率 | -40.88% | — |
资本回报率 | -54.41% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -1620.50万 | -86.01% |
来自运营的现金 | -721.40万 | 19.61% |
投资现金 | 739.40万 | -66.02% |
融资现金 | 100.70万 | 67.83% |
现金净变动 | 118.70万 | -91.12% |
自由现金流 | -534.81万 | 35.08% |
简介
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
CEO
成立时间
1999
员工数量
207
